FI81363B - Foerfarande foer pastoerisering av preparat av blodkoaguleringsfaktorerna ii, vii, ix och x. - Google Patents
Foerfarande foer pastoerisering av preparat av blodkoaguleringsfaktorerna ii, vii, ix och x. Download PDFInfo
- Publication number
- FI81363B FI81363B FI843909A FI843909A FI81363B FI 81363 B FI81363 B FI 81363B FI 843909 A FI843909 A FI 843909A FI 843909 A FI843909 A FI 843909A FI 81363 B FI81363 B FI 81363B
- Authority
- FI
- Finland
- Prior art keywords
- solution
- factors
- mmol
- vii
- process according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/04—Heat
Claims (7)
1. Förfarande för framställning av ett praktiskt 5 taget virusfritt och hepatitsäkert preparat av blodkoaku- leringsfaktorerna II, VII, IX och X genom uppvärmning av en dessa faktorer innehällande, vattenhaltig vätska, i närvaro av en aminosyra och en sackarid, känne -t e c k n a t därav, att uppvärminingen sker i närvaro av 10 kalciumjoner (1-50 mmol/1) och en kelatbildare (1-20 mmol/1) och eventuellt i närvaro av antitrorabin III (0,2 -2 E/ml) och/eller heparin (2-20 USP-E/ml).
2. Förfarande enligt patentkravet 1, känne-t e c k n a t därav, att koncentrationen av kalciumjoner 15 är 25 - 50 mmol/1.
3. Förfarande enligt patentkravet 1, känne-t e c k n a t därav, att kelatbildaren är en alifatisk aza-tri- eller -tetrakarboxylsyra med 6-20 kolatomer och 1 eller 2 kväveatomen, eller dess lösliga alkalisalt. 20
4. Förfarande enligt patentkravet 1, känne- t e c k n a t därav, att koncentrationen av kelatbildaren är 5 mmol/1.
5. Förfarande enligt patentkravet 1, känne-t e c k n a t därav, att uppvärmningen sker i närvaro av 25 antitrombin III, heparin, (25 - 50 mmol/1) kalciumjoner, EDTA, (1-3 mol/1 av) glycin, alanin eller serin, före-trädesvis glycin, och (20 - 60 g/100 g lösning av) en sackaridlösning, företrädesvis (1-3 mol/1) glycin och (20 - 60 g/100 g lösning av) sackaros, tili en temperatur 30 mellan 30 och 100°C, företrädesvis 60 - 100°C under en tid av 1 minut tili 48 timmar, företrädesvis 8-12 timmar.
6. Förfarande enligt patentkravet 1, känne-t e c k n a t därav, att den vattenhaltiga lösningen är citratplasma eller en plasma- eller placentafraktion. 35
7. Förfarande enligt patentkravet 1, känne- t e c k n a t därav, att den vattenhaltiga lösningen är ett koncentrat av faktorerna II, VII, IX och X. li
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833336631 DE3336631A1 (de) | 1983-10-08 | 1983-10-08 | Verfahren zur pasteurisierung von plasma oder von konzentraten der blutgerinnungsfaktoren ii, vii, ix und x |
| DE3336631 | 1983-10-08 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI843909A0 FI843909A0 (fi) | 1984-10-04 |
| FI843909L FI843909L (fi) | 1985-04-09 |
| FI81363B true FI81363B (fi) | 1990-06-29 |
| FI81363C FI81363C (sv) | 1990-10-10 |
Family
ID=6211328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI843909A FI81363C (sv) | 1983-10-08 | 1984-10-04 | Förfarande för pastörisering av preparat av blodkoaguleringsfaktorerna II, VII, IX och X |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6346277B1 (sv) |
| EP (1) | EP0137428B1 (sv) |
| AT (1) | ATE42899T1 (sv) |
| AU (1) | AU590191B2 (sv) |
| CA (1) | CA1246444A (sv) |
| DE (2) | DE3336631A1 (sv) |
| DK (1) | DK167598B1 (sv) |
| ES (1) | ES8605677A1 (sv) |
| FI (1) | FI81363C (sv) |
| IL (1) | IL73189A (sv) |
| MX (1) | MX167398B (sv) |
| NZ (1) | NZ209784A (sv) |
| PT (1) | PT79318B (sv) |
| ZA (1) | ZA847823B (sv) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3602688A1 (de) * | 1986-01-30 | 1987-08-06 | Behringwerke Ag | Verfahren zur gewinnung und herstellung eines pasteurisierten praeparates von (alpha)(pfeil abwaerts)2(pfeil abwaerts)-antiplasmin |
| FR2631830B1 (fr) * | 1988-05-25 | 1991-06-21 | Lille Transfusion Sanguine | Concentre de facteur ix de haute purete, sa preparation et son utilisation en therapeutique |
| DE3877529T2 (de) * | 1987-10-23 | 1996-11-07 | Centre Regional De Transfusion | Herstellung von hoch-gereingtem menschlichen Faktor IX sowie anderem Plasmaproteinkonzentrat und dessen therapeutische Verwendung. |
| DK18288D0 (da) * | 1988-01-15 | 1988-01-15 | Nordisk Gentofte | Fremgangsmaade til pasteurisering af vandige oploesninger af faktor viii |
| DE3938907C2 (de) * | 1989-11-24 | 1999-11-04 | Dade Behring Marburg Gmbh | Mittel zum Lagern und Suspendieren von Zellen, insbesondere Erythrozyten |
| DE4001451A1 (de) * | 1990-01-19 | 1991-08-01 | Octapharma Ag | Stabile injizierbare loesungen von faktor viii und faktor ix |
| FR2664165B1 (fr) * | 1990-07-03 | 1992-10-16 | Lille Transfusion Sanguine | Composition pour stabiliser le plasma sanguin en cours de pasteurisation. |
| PT2130554E (pt) | 1999-02-22 | 2012-11-19 | Univ Connecticut | Formulações de factor viii isentas de albumina |
| US6245548B1 (en) * | 2000-03-09 | 2001-06-12 | American National Red Cross | Activation of pure prothrombin to thrombin with about 30% to about 40% sodium citrate |
| GB0216002D0 (en) * | 2002-07-10 | 2002-08-21 | Nat Blood Authority | Process and composition |
| DE20218363U1 (de) * | 2002-11-26 | 2004-01-15 | Meltem Wärmerückgewinnung GmbH & Co. KG | Luftaustauschsystem für die Entlüftung wenigstens eines Raums eines Gebäudes |
| US20040229778A1 (en) * | 2003-05-13 | 2004-11-18 | Elmaleh David R. | Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases |
| US20100168018A1 (en) | 2008-11-07 | 2010-07-01 | Baxter International Inc. | Factor viii formulations |
| EP3579857B1 (en) * | 2017-02-09 | 2022-04-06 | CSL Behring GmbH | A blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedings |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4364861A (en) * | 1980-05-27 | 1982-12-21 | Cutter Laboratories, Inc. | Blood-coagulation-promoting products and methods of preparing them |
| US4391746A (en) * | 1980-05-27 | 1983-07-05 | Cutter Laboratories, Inc. | Blood-coagulation-promoting products and methods of preparing them |
| US4314997A (en) | 1980-10-06 | 1982-02-09 | Edward Shanbrom | Purification of plasma protein products |
| US4412985A (en) | 1980-10-06 | 1983-11-01 | Edward Shanbrom | Depyrogenation process |
| DE3173208D1 (en) * | 1980-10-06 | 1986-01-23 | Edward Shanbrom | Method of reducing undesirable activities of biological and pharmaceutical products |
| US4315919A (en) | 1980-10-06 | 1982-02-16 | Edward Shanbrom | Depyrogenation process |
| DE3043857A1 (de) * | 1980-11-21 | 1982-07-08 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ii und vii |
| DE3045153A1 (de) * | 1980-11-29 | 1982-07-08 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x |
| DE3230849A1 (de) * | 1982-08-19 | 1984-02-23 | Behringwerke Ag, 3550 Marburg | Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung |
| DE3237512A1 (de) | 1982-10-09 | 1984-04-12 | Behringwerke Ag, 3550 Marburg | Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat |
| FR2681867B1 (fr) * | 1991-09-26 | 1993-12-31 | Pasteur Merieux Serums Vaccins | Procede de purification du facteur viii et preparations obtenues. |
| IT1262899B (it) * | 1992-03-27 | 1996-07-22 | Sclavo Spa | Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano |
-
1983
- 1983-10-08 DE DE19833336631 patent/DE3336631A1/de not_active Withdrawn
-
1984
- 1984-09-28 DE DE8484111601T patent/DE3478087D1/de not_active Expired
- 1984-09-28 EP EP84111601A patent/EP0137428B1/de not_active Expired
- 1984-09-28 AT AT84111601T patent/ATE42899T1/de not_active IP Right Cessation
- 1984-10-04 FI FI843909A patent/FI81363C/sv not_active IP Right Cessation
- 1984-10-04 PT PT79318A patent/PT79318B/pt unknown
- 1984-10-05 AU AU33882/84A patent/AU590191B2/en not_active Ceased
- 1984-10-05 MX MX008473A patent/MX167398B/es unknown
- 1984-10-05 CA CA000464909A patent/CA1246444A/en not_active Expired
- 1984-10-05 DK DK480184A patent/DK167598B1/da not_active IP Right Cessation
- 1984-10-05 NZ NZ209784A patent/NZ209784A/en unknown
- 1984-10-05 ES ES536549A patent/ES8605677A1/es not_active Expired
- 1984-10-05 ZA ZA847823A patent/ZA847823B/xx unknown
- 1984-10-08 IL IL73189A patent/IL73189A/xx not_active IP Right Cessation
-
1995
- 1995-03-31 US US08/415,166 patent/US6346277B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES536549A0 (es) | 1985-12-16 |
| NZ209784A (en) | 1987-10-30 |
| FI843909L (fi) | 1985-04-09 |
| ZA847823B (en) | 1985-05-29 |
| DK167598B1 (da) | 1993-11-29 |
| FI81363C (sv) | 1990-10-10 |
| DE3478087D1 (en) | 1989-06-15 |
| US6346277B1 (en) | 2002-02-12 |
| AU3388284A (en) | 1985-04-18 |
| PT79318B (de) | 1986-10-20 |
| IL73189A (en) | 1988-06-30 |
| CA1246444A (en) | 1988-12-13 |
| DE3336631A1 (de) | 1985-04-18 |
| EP0137428A3 (en) | 1985-08-07 |
| EP0137428B1 (de) | 1989-05-10 |
| ATE42899T1 (de) | 1989-05-15 |
| AU590191B2 (en) | 1989-11-02 |
| DK480184A (da) | 1985-04-09 |
| DK480184D0 (da) | 1984-10-05 |
| EP0137428A2 (de) | 1985-04-17 |
| MX167398B (es) | 1993-03-22 |
| IL73189A0 (en) | 1985-01-31 |
| FI843909A0 (fi) | 1984-10-04 |
| ES8605677A1 (es) | 1985-12-16 |
| PT79318A (de) | 1984-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1182047A (en) | Process for the production of blood-clotting factors and preparation of factors ix and x, prepared by this process | |
| US4404187A (en) | Method for rendering factors II and VII hepatitis-safe with a chelating agent | |
| CA1126652A (en) | Antithrombin preparation and process for the production thereof | |
| FI81363B (fi) | Foerfarande foer pastoerisering av preparat av blodkoaguleringsfaktorerna ii, vii, ix och x. | |
| US4915945A (en) | Process for the preparation of the C1 inactivator | |
| US5981254A (en) | Process for producing thrombin from plasma | |
| US4424206A (en) | Process for heat treatment of aqueous solution containing cold insoluble globulin to inactivate hepatitis virus | |
| JPS6254286B2 (sv) | ||
| US4562072A (en) | Process for the pasteurization of antihemophilic cryoprecipitate (AHC) and antihemophilic cryoprecipitate prepared thereby | |
| US4379085A (en) | Heat stabilization of plasma proteins | |
| AU2003244850A1 (en) | Processes for the preparation of fibrinogen | |
| JPH0580455B2 (sv) | ||
| HU210026B (en) | Heparin-free composition for stabilizing blood plasma during pasteurization, and process for pasteurizing blood plasma | |
| AU1568199A (en) | Method for preparing by filtration a virally secure factor viii solution | |
| EP0011739B1 (en) | Process for obtaining blood coagulation factor xiii derived from human placenta | |
| US4822872A (en) | Method of purifying factor VIII | |
| EP0052874A1 (en) | Method for synthesizing procoagulant factor VIII activity | |
| RU2045902C1 (ru) | Состав для стабилизации плазмы крови в ходе пастеризации и способ пастеризации плазмы крови | |
| JPH0530812B2 (sv) | ||
| JPH01305036A (ja) | 血漿蛋白成分の加熱処理方法および血漿蛋白成分製剤 | |
| CA2228031A1 (en) | Doubly virus-inactivated human blood plasma, blood plasma derivatives produced therefrom and method for their production | |
| DK1037923T4 (en) | A process for the filtration to produce a solution with regard to virus-safe factor VIII |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Transfer of assignment of patent |
Owner name: CENTEON PHARMA GMBH |
|
| MM | Patent lapsed |
Owner name: AVENTIS BEHRING GMBH |